Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis

Last updated: September 6, 2023
Sponsor: Taipei Veterans General Hospital, Taiwan
Overall Status: Active - Recruiting

Phase

N/A

Condition

Idiopathic Pulmonary Fibrosis

Lung Injury

Cystic Fibrosis

Treatment

"LARGAN" ECG Holter

Clinical Study ID

NCT06027372
2020-04-016BC
  • Ages > 50
  • All Genders

Study Summary

The goal of this observational study is to compare the overnight heart rate variability (HRV) and nocturnal oxygen saturation (SpO2) in patients with idiopathic pulmonary fibrosis (IPF). The main questions it aims to answer are: (1). if there are correlations between pulmonary function test and HRV and overnight SpO2; (2). if HRV and SpO2 can predict the occurrence of acute exacerbation in patients with IPF. Participants will be asked to examine pulmonary function test (including lung volumes and six-minute walk test) and wear pulse oxygenation recorder and "LARGAN" ECG Holter" ("LARGAN HEALTH TECHNOLOGY" Sleep Apnea And Sleep Quality Examination System) during sleep.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • individuals meet the diagnosis of idiopathic pulmonary fibrosis
  • individuals agree to participate this study and sign the informed consent
  • individuals have cognitive and behavioral abilities

Exclusion

Exclusion Criteria:

  • age less than 50 years old
  • individuals refuse to participate this study and sign the informed consent
  • individuals of unclear consciousness

Study Design

Total Participants: 70
Treatment Group(s): 1
Primary Treatment: "LARGAN" ECG Holter
Phase:
Study Start date:
May 21, 2020
Estimated Completion Date:
June 30, 2024

Connect with a study center

  • Taipei Veterans General Hospital

    Taipei,
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.